The long term use of proton pump inhibitors (PPIs), a class of drugs widely used to treat acid reflux and ulcers, may not be linked to any increased risk of developing gastric (stomach) cancer, finds ...
Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...
Accelerating phase 2 clinical development with real-world data (RWD): An external control arm (ECA) pilot in HER2-positive (HER2+) metastatic breast cancer (mBC). This is an ASCO Meeting Abstract from ...
Since their development and widespread adoption in the late 1980s, proton pump inhibitors (PPI) have transformed the field of gastroenterology. Their high efficacy and favorable safety profiles have ...
Please provide your email address to receive an email when new articles are posted on . Findings showed use was associated with fatigue and lower health-related quality of life. The associations were ...
You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: I am a retired male over 65 and a former occasional cigar ...
A recent Scientific Reports study investigates whether the association between proton pump inhibitors (PPIs) and the use of histamine-2 receptor antagonists (H2RA) affects the risk of chronic kidney ...
Officials with the FDA have approved the first generic omeprazole oral paste for the treatment of gastric ulcers and ...
"The finding of no association may offer relief for patients who need long-term proton pump inhibitor therapy in the treatment of gastroesophageal reflux disease or for other clear indications." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results